Not all patients with CLL involve therapy. Irrespective of all latest advances, the iwCLL however suggests watchful observation for clients with asymptomatic disease.86 This recommendation relies on no less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).: In